CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,387,000 | -20.7% | 30,500 | -7.9% | 0.60% | -8.0% |
| Q1 2018 | $1,748,000 | -62.0% | 33,100 | -51.1% | 0.65% | -53.6% |
| Q4 2017 | $4,600,000 | -1.6% | 67,650 | +19.2% | 1.41% | -0.8% |
| Q3 2017 | $4,676,000 | +57.8% | 56,750 | +79.3% | 1.42% | +69.1% |
| Q2 2017 | $2,963,000 | +46.1% | 31,650 | -0.6% | 0.84% | +28.5% |
| Q1 2017 | $2,028,000 | +148.2% | 31,850 | +73.1% | 0.65% | +92.9% |
| Q4 2016 | $817,000 | +173.2% | 18,400 | +121.7% | 0.34% | +204.5% |
| Q3 2016 | $299,000 | – | 8,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |